Global Eyelid Scrub Market By Product Type (Pre‑moistened scrubs, Spray scrubs, Foam scrubs, Liquid scrubs, Dry pad scrubs and Others), By Application (Allergies, Dry eyes, Blepharitis treatment, Meibomian Gland Dysfunction (MGD) and Other), By Distribution Channel (Online pharmacies, Retail pharmacies, and Hospital pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview

The Global Eyelid Scrub Market size is expected to be worth around US$ 7.00 Billion by 2034 from US$ 3.56 Billion in 2024, growing at a CAGR of 7.0% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 36.8% share with a revenue of US$ 1.31 Billion.

The growth of the market is driven by increasing awareness of eye hygiene, the rise in eye conditions like dry eyes and blepharitis, and the growing preference for over-the-counter (OTC) self-care products. Eyelid scrubs are essential for maintaining eyelid hygiene and preventing conditions like meibomian gland dysfunction (MGD) and blepharitis. These products are particularly used in both clinical settings and at home for daily eye care, supported by a rising number of consumer eye-health initiatives.

Meibomian Gland Dysfunction (MGD) is highly prevalent worldwide, with its global occurrence ranging from 3.5% to over 70%, depending on study methodologies. The condition generally increases with age, affecting a significant portion of older adults, with up to 70% of individuals over 60 years old impacted. MGD is often more prevalent in Asian populations and is considered the primary cause of dry eye disease, as it leads to the blockage of oil glands in the eyes.

The rising prevalence of digital eye strain from increased screen time, coupled with an aging population more prone to chronic eye conditions, is driving consumer demand for eyelid scrubs in forms like wipes, foams, and sprays. Lifestyle factors such as exposure to pollutants and allergies also contribute to this trend. Additionally, the growing focus on preventive eye care, particularly the demand for organic and preservative-free products, is further fueling adoption, especially through e-commerce and pharmacies.

North America holds the largest market share due to advanced healthcare systems and a high incidence of dry eye conditions, while the Asia-Pacific region, including India, is experiencing the fastest growth driven by urbanization, increased online access, and government hygiene initiatives. Although emerging markets face challenges such as limited awareness, they benefit from rising disposable incomes. North America leads due to advanced healthcare and high dry eye incidence, while Asia-Pacific, including India, grows fastest from urbanization, online access, and government hygiene initiatives. Emerging markets face restraints from limited awareness but benefit from rising disposable incomes.

Key Takeaways

• In 2024, the market generated a revenue of US$ 3.56 Billion, with a CAGR of 7.0%, and is expected to reach US$ 7.00 Billion by the year 2034.
• The Product Type segment is divided into Pre‑moistened scrubs, Spray scrubs, Foam scrubs, Liquid scrubs, Dry pad scrubs, and Others, with Pre‑moistened scrubs taking the lead in 2024 with a market share of 55.5%
• The Application segment is divided into Allergies, Dry eyes, Blepharitis treatment, Meibomian Gland Dysfunction (MGD), and Other, with Dry eyes taking the lead in 2024 with a market share of 42.7%
• The Distribution Channel segment is divided into Online pharmacies, Retail pharmacies, and Hospital pharmacies, with Online pharmacies taking the lead in 2024 with a market share of 48.9%
• North America led the market by securing a market share of 36.8% in 2024.

Product Type Analysis

Pre-moistened scrubs dominate the Eyelid Scrub Market with a market share of 55.5% in 2024. These products are popular due to their convenience and ease of use, making them the most common choice for daily eyelid hygiene. Pre-moistened wipes are used to clean debris, oil, and bacteria from the eyelids, helping prevent and manage eye conditions like blepharitis and dry eyes. Major brands like OCuSOFT and Alcon lead this segment.

Spray scrubs hold a smaller share 12.3% of the market but are gaining popularity due to their non-contact and easy-to-use design. Spray scrubs are effective for users with sensitive skin or those who prefer a gentle application. These are particularly useful in clinical environments and are considered ideal for reducing cross-contamination risks. Foam scrubs are often seen as premium products that provide a thicker application, making them ideal for targeted cleaning, especially in cases of severe eye irritation. Though they offer a luxurious experience, foam scrubs have yet to achieve widespread adoption compared to pre-moistened versions.

Application Analysis

Dry eyes are the largest application segment in the Eyelid Scrub Market, accounting for 42.7% of the market share in 2024. Dry eyes, especially as a result of aging or environmental factors, drive the need for daily eyelid cleaning products. Eyelid scrubs help remove irritants and excess oils, which can exacerbate dry eye symptoms, thus enhancing comfort and supporting healthy tear production.

According to a study published on JAMA Network, ten studies reported on the prevalence of dry eye, two on its incidence, and three on the prevalence of Meibomian Gland Dysfunction (MGD). A meta-analysis estimated that the global prevalence of dry eye is 8.1% (with a range of 4.9% to 13.1%) based on data from 9,808,758 participants across three studies. The prevalence of MGD was estimated at 21.2% (with a range of 7.2% to 48.3%) from three studies involving 19,648 participants. The incidence of dry eye was found to be 3.5% in individuals aged 18 and older, and 7.8% in those aged 68 and older.

Blepharitis treatment represents 22.3% of the market. Blepharitis, an inflammation of the eyelids, often caused by bacterial infections or skin conditions, requires proper eyelid hygiene to prevent flare-ups. Eyelid scrubs are essential in managing this condition, as they help reduce inflammation, improve symptoms, and support healing.

Meibomian Gland Dysfunction (MGD) accounts for about 15.0% of the market. MGD, a common cause of dry eyes, affects the glands responsible for oil production in the eyelids. Eyelid scrubs help unclog these glands, reducing irritation and improving tear quality. MGD-related scrubs are typically sold in specialized formulations to cater to users with chronic conditions.

Distribution Channel Analysis

Online pharmacies hold around 48.9% of the market share, with growing demand as consumers increasingly prefer purchasing healthcare products online. The convenience, along with the ability to access specialized brands, fuels the segment’s growth. Consumers who prefer privacy or live in rural areas may prefer purchasing through online platforms. Retail pharmacies lead the distribution segment with 50% market share in 2024. These pharmacies offer easy access to a wide variety of eyelid scrub products, often with OTC availability. Customers can easily find these products in major chains and independent stores.

Hospital pharmacies account for the remaining 23.9% of the market. Hospital pharmacies distribute eyelid scrubs primarily in clinical settings, where they are recommended for treating conditions like blepharitis and MGD. These sales are mostly B2B in nature, driven by healthcare professionals prescriptions.

Key Market Segments

By Product Type

• Pre‑moistened scrubs
• Spray scrubs
• Foam scrubs
• Liquid scrubs
• Dry pad scrubs
• Others

By Application

• Allergies
• Dry eyes
• Blepharitis treatment
• Meibomian Gland Dysfunction (MGD)
• Others

By Distribution Channel

• Online pharmacies
• Retail pharmacies
• Hospital pharmacies

Drivers

Increasing Prevalence of Ocular Surface Disorders and Growing Awareness of Eye Health Hygiene

The increasing prevalence of ocular surface disorders, particularly dry eye disease (DED), blepharitis, and Meibomian gland dysfunction (MGD), is a primary driver for the Eyelid Scrub Market. Dry eye disease is one of the most common ocular conditions, affecting an estimated 11.6% of the global population, with symptomatic DED affecting about 9.1% globally. Factors such as prolonged screen time, environmental pollutants, aging populations, and the growing use of contact lenses contribute to the increasing incidence of these conditions.

As awareness grows regarding the importance of maintaining eyelid hygiene to manage and prevent these conditions, the demand for eyelid scrubs has surged. For instance, in the U.S., over 16 million people suffer from dry eye disease, and the market for dry eye treatments, including eyelid scrubs, is expected to grow by 5.6% annually through 2030.

Studies show that eyelid scrubs effectively remove debris, bacteria, and excess oils that contribute to dry eye symptoms and blepharitis, further fueling their demand. The growing recognition of eye health, coupled with advancements in over-the-counter eyelid scrub formulations, has made these products more accessible and popular among consumers. This trend is expected to drive the market, as more individuals seek self-care solutions to manage these chronic eye conditions.

Restraints

Regulatory and Compliance Challenges in Ophthalmic-Grade Products

One significant restraint in the Eyelid Scrub Market is the stringent regulatory requirements and compliance challenges associated with ophthalmic-grade products. Eyelid scrubs are used near the delicate ocular region, and any product used around the eyes must adhere to rigorous safety, formulation, and labeling standards. This high level of scrutiny from regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), ensures that only safe and effective products reach the market.

However, the complexity of these regulatory processes can increase costs for manufacturers, particularly in emerging markets where regulatory frameworks may not be as developed or uniform. The lack of standardized guidelines across different regions can delay product approvals and restrict market entry for new companies. In countries with more stringent regulations, such as the U.S., the FDA requires manufacturers to comply with specific ophthalmic safety standards, increasing both operational and testing costs.

Additionally, the necessity for continuous testing to ensure product safety and efficacy can lead to increased R&D and marketing expenses. This financial burden may limit market access for smaller companies or reduce the affordability of products in price-sensitive regions. Consequently, these regulatory hurdles can slow product launches and hinder the growth of the eyelid scrub market, particularly in developing economies.

Opportunities

Development of Preservative-Free and Sensitive-Skin Formulations

An exciting opportunity within the Eyelid Scrub Market lies in the development of preservative-free, sensitive-skin, and allergy-targeted eyelid scrub formulations. As more consumers with sensitive skin, allergies, or specific eye conditions seek products that are gentler on their skin, there has been a noticeable shift toward hypoallergenic and preservative-free formulations. For example, products like OCuSOFT’s Hypochlor™ eyelid scrub and Avenova’s preservative-free solution have gained significant traction among consumers who want a gentler alternative to traditional scrubs.

It is estimated that about 10–15% of individuals with ocular conditions like dry eyes and blepharitis also experience allergic reactions that worsen symptoms, making preservative-free options highly attractive. The demand for these sensitive formulations is expected to grow rapidly, particularly as more consumers become aware of potential irritants in everyday eye-care products. Research also shows that consumers with sensitive skin are 35% more likely to opt for products specifically labeled as “dermatologist-tested” or “for sensitive skin.”

Additionally, as the awareness of eyelid hygiene as a self-care practice grows, especially in the context of increased screen time, the demand for gentle, non-irritating eye-care products will rise. Manufacturers who can innovate and create these specialized formulations stand to capture a larger share of the market, particularly in developed regions where consumers are more health-conscious and willing to spend on premium products.

Impact of Macroeconomic / Geopolitical Factors

Macroeconomic and geopolitical factors significantly influence the Eyelid Scrub Market, particularly in terms of pricing, supply chain stability, and market access. Economic downturns or periods of inflation can affect consumer spending on non-essential goods, such as personal care products. For instance, during economic recessions, consumers tend to prioritize essential healthcare over luxury or convenience items, potentially reducing the market size for non-prescription products like eyelid scrubs. Furthermore, inflation-driven increases in raw material costs, including packaging and active ingredients, can lead to higher production costs, which manufacturers may pass on to consumers, leading to price sensitivity in the market.

Geopolitical instability, such as trade restrictions or political unrest, can disrupt global supply chains and impact the availability of key ingredients, like certain active compounds used in eyelid scrubs. This can lead to delays in production or shipping, particularly for brands that rely on international suppliers. Additionally, geopolitical factors may affect the regulatory landscape, with regions enforcing stricter safety and quality standards, which may hinder market entry for new brands or delay product approvals.

Latest Trends

Growth of E-Commerce and Online Pharmacies

A significant trend in the Eyelid Scrub Market is the rapid growth of e-commerce and online pharmacies, which has reshaped the way consumers purchase eye-care products. The shift towards digital shopping platforms, accelerated by the COVID-19 pandemic, has significantly impacted the sales of over-the-counter health products, including eyelid scrubs.

Consumers increasingly prefer the convenience of purchasing health products online, particularly as they seek privacy and ease of access to a wide range of products. E-commerce also provides an opportunity for brands to expand their reach beyond local retail stores, allowing smaller or niche brands to capture larger market segments. In addition, online platforms often offer detailed product descriptions, reviews, and comparisons, which help consumers make informed purchasing decisions.

As a result, companies are increasingly focusing on strengthening their online presence, offering direct-to-consumer (DTC) sales through their websites and partnering with major online marketplaces like Amazon and Walmart. This trend is expected to drive the growth of the Eyelid Scrub Market as it offers more affordable and convenient purchasing options to a broader, tech-savvy consumer base. Moreover, online pharmacies often offer subscription services, increasing customer loyalty and repeat purchases.

Regional Analysis

North America is leading the Eyelid Scrub Market

The region benefits from high awareness about ocular health, a large aging population, and a high prevalence of eye ailments, which drive demand for eyelid hygiene products. Established healthcare infrastructure and ready access to over‑the‑counter eye‑care products strengthen market penetration. Leading players such as OCuSOFT, Alcon, Bausch & Lomb and Allergan are active in the region, offering a broad portfolio of pre‑moistened wipes, medicated scrubs and preservative‑free cleansers, contributing to mature and stable demand. Steady growth in digital eye‑strain and dry‑eye incidence, combined with strong consumer preference for self‑care, keeps North America ahead in absolute market value.

The Asia Pacific region is expected to experience the highest CAGR during the forecast period

Asia‑Pacific emerges as the fastest‑growing region in the global eye‑care products market, which includes eyelid scrubs, driven by rising disposable incomes, growing urbanisation and increasing awareness of eye hygiene. Rapid expansion of retail and online distribution channels in countries such as India, China and South Korea fuels greater product reach and affordability. Rising prevalence of digital device use, growing rates of dry‑eye and blepharitis, and increasing demand for OTC self‑care solutions contribute to accelerating adoption of eyelid scrubs.

Manufacturers are also introducing products tailored to sensitive skin and local preferences (e.g. preservative‑free, hypoallergenic cleansers), which appeal to a broad demographic. The combination of expanding eye‑care awareness, health infrastructure upgrades and demographic shifts suggests that Asia‑Pacific offers the highest growth potential in the near to mid-term.

Key Regions and Countries

North America

• US
• Canada

Europe

• Germany
• France
• The UK
• Spain
• Italy
• Russia
• Netherland
• Rest of Europe

Asia Pacific

• China
• Japan
• South Korea
• India
• Australia
• New Zealand
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE
• Rest of MEA

Key Players Analysis

Key players in the market include Allergan, Prestige Consumer Healthcare, Inc., Bausch + Lomb Incorporated, Eye Love (Heyedrate), Cliradex, Alcon Inc., Avenova (part of NovaBay Pharmaceuticals), OCuSOFT Inc., ROHTO PHARMACEUTICAL CO., LTD., Théa Pharma Inc., and Other key players.

Allergan was a leading global pharmaceutical and eye‑care company, now part of AbbVie. It specializes in therapies for ocular surface diseases, dry eye, glaucoma and retinal disorders. Its legacy eye‑care products include lubricating eye drops and other ophthalmic treatments, making it a key player in medical eye care. Allergan built a strong presence in OTC and prescription‑eye‑care products, and through its eye‑care portfolio helped shape standards for ocular hygiene and ophthalmic treatment globally.

Prestige Consumer Healthcare, Inc. is a U.S.–based company focused on over‑the‑counter (OTC) health and personal care products. Its product portfolio spans many categories including eye care (e.g. eye drops and eye‑hygiene solutions), digestive care, pain relief, skin care and more. The company markets recognizable consumer health brands (e.g. under eye/ear/nose‑throat portfolio) and distributes broadly via retail pharmacies and mass‑market retail, enabling wide access for everyday self‑care — which may include eyelid hygiene products.

Bausch + Lomb Incorporated is one of the world’s largest and longest‑established eye‑health companies, with origins dating back to 1853. It offers a wide range of eye‑care products including contact lenses, lens‑care solutions, over‑the‑counter eye drops, and surgical ophthalmic devices. Through its broad vision‑care, pharmaceuticals, and surgical segments, Bausch + Lomb serves both consumer self‑care and professional medical eye‑care markets.

Top Key Players

• Allergan (AbbVie)
• Prestige Consumer Healthcare, Inc.
• Bausch + Lomb Incorporated
• Eye Love (Heyedrate)
• Cliradex
• Alcon Inc.
• Avenova (part of NovaBay Pharmaceuticals)
• OCuSOFT Inc.
• ROHTO PHARMACEUTICAL CO., LTD.
• Théa Pharma Inc.
• Other key players

Recent Developments

• In October 2025, Bausch + Lomb Incorporated announced that it will present more than 20 scientific studies at upcoming major eye‑care conferences (2025 events organized by the American Academy of Optometry and the American Academy of Ophthalmology), covering products across its portfolio including solutions for dry eye and ocular surface disease.
• In January 2022, OCuSOFT Inc. launched a specialized product OCuSOFT Lid Scrub Allergy Eyelid Cleanser a pre‑moistened pad designed to remove oil, pollen, debris and environmental allergens from eyelids, aiming at allergy‑related eye irritation and inflammation.
• In May 2024, NovaBay Pharmaceuticals, Inc. announced the launch of Avenova product bundles targeting individuals with multifactorial dry‑eye symptoms — a move illustrating its push into comprehensive eye‑health management beyond just scrubs.

Report Scope